¼¼°èÀÇ Á¾¾ç »öÀü ±â±â ½ÃÀå : ±âȸ ¹× Àü·«(-2033³â)
Tumor Embolization Devices Global Market Opportunities And Strategies To 2033
»óǰÄÚµå : 1477068
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : 2024³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 281 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,000 £Ü 7,095,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,643,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,191,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è Á¾¾ç »öÀü ±â±â ½ÃÀåÀº 2018³â 11¾ï 4,318¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2023³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 4.0% ÀÌ»óÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¬±¸°³¹ßºñ ÁöÃâ Áõ°¡

ÀÇ·á ºÐ¾ßÀÇ ¿¬±¸°³¹ßºñ Áõ°¡´Â Áö±Ý±îÁö Á¾¾ç »öÀü ±â±â ½ÃÀåÀ» ÁÖµµÇØ ¿Ô½À´Ï´Ù. R&D ºñ¿ë Áõ°¡´Â Á¾¾ç »öÀü¼ú ÀåÄ¡ÀÇ »õ·Î¿î Àç·á¿Í ¼³°è¿¡ ´ëÇÑ Å½±¸¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ±× °á°ú, º¸´Ù È¿À²ÀûÀ̰í È¿°úÀûÀÎ ÀåÄ¡°¡ °³¹ßµÇ¾î Á¾¾çÀ» º¸´Ù Á¤È®ÇÏ°Ô Ä¡·áÇÒ ¼ö ÀÖ°Ô µÇ¾î ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. R&D ÅõÀÚ´Â Á¾¾ç »öÀü¼ú ÀåÄ¡¿¡ ÷´Ü ¿µ»ó ±â¼úÀ» ÅëÇÕÇÏ´Â µ¥ ±â¿©ÇÕ´Ï´Ù. ¿©±â¿¡´Â MRI(ÀÚ±â°ø¸í¿µ»ó) ¹× CT(ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ) ½ºÄµ°ú °°Àº ½Ç½Ã°£ ¿µ»ó ¾ç½ÄÀ» ÅëÇÕÇÏ¿© »öÀü¼ú Áß Á¾¾ç°ú ÁÖº¯ Á¶Á÷À» ´õ Àß º¼ ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀÌ Æ÷ÇԵ˴ϴÙ. ¿¹¸¦ µé¾î, ¹Ì±¹ µðÁöÅÐ ¸¶ÄÉÆÃ È¸»ç WebFX¿¡ µû¸£¸é ÀÇ·á ±â¼ú ±â¾÷Àº ÀϹÝÀûÀ¸·Î ¿¬°£ ¸ÅÃâÀÇ 5.1%¸¦ R&D ÇÁ·ÎÁ§Æ®¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹°ú ¿µ±¹ ÀÇ·á ±â¼ú ±â¾÷ÀÇ R&D ºñ¿ëÀº 11.5% Áõ°¡Çß½À´Ï´Ù. µû¶ó¼­ R&D ºñ¿ë Áõ°¡´Â Áö³­ ±â°£ µ¿¾È Á¾¾ç »öÀü ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¸ñÂ÷

Á¦3Àå Ç¥ ¸®½ºÆ®

Á¦4Àå ±×·¡ÇÁ ¸®½ºÆ®

Á¦5Àå º¸°í¼­ÀÇ ±¸Á¶

Á¦6Àå ½ÃÀå Æ¯Â¡

Á¦7Àå Á¾¾ç »öÀü ±â±â ½ÃÀå : °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦8Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦9Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

Á¦10Àå ¼¼°èÀÇ Á¾¾ç »öÀü ±â±â ½ÃÀå : ¼¼ºÐÈ­

Á¦11Àå Á¾¾ç »öÀü ±â±â ½ÃÀå : Áö¿ª¡¤±¹°¡º° ºÐ¼®

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦13Àå ¼­À¯·´ ½ÃÀå

Á¦14Àå µ¿À¯·´ ½ÃÀå

Á¦15Àå ºÏ¹Ì ½ÃÀå

Á¦16Àå ³²¹Ì ½ÃÀå

Á¦17Àå Áßµ¿ ½ÃÀå

Á¦18Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦19Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦20Àå °æÀï º¥Ä¡¸¶Å·

Á¦21Àå °æÀï ´ë½Ãº¸µå

Á¦22Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦23Àå ±âȸ¿Í Àü·«

Á¦24Àå Á¾¾ç »öÀü ±â±â ½ÃÀå : °á·Ð°ú Á¦¾È

Á¦25Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Tumor embolization devices are specialized medical tools used in the process of embolization, a minimally invasive procedure that blocks blood vessels to prevent blood flow to cancerous tumors or other abnormal growths.

The tumor embolization devices market consists of sales, by entities (organizations, sole traders or partnerships), of tumor embolization devices that are crucial in the treatment of various types of tumors, both cancerous and non-cancerous, by delivering embolic agents directly to the site of the tumor.

The global tumor embolization devices market was valued at $1,143.18 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 4.0%.

Increased Research And Development Spending

Rising research and development spending in the medical sector drove the tumor embolization devices market in the historic period. Increased research and development funding allows for the exploration of novel materials and designs for tumor embolization devices. This results in the development of more efficient and effective devices that can better target and treat tumors, leading to improved patient outcomes. R&D investments can contribute to the integration of advanced imaging technologies into tumor embolization devices. This may include the incorporation of real-time imaging modalities, such as MRI (magnetic resource imaging) or CT (computed tomography) scans, providing better visualization of tumors and surrounding tissues during the embolization procedure. For instance, according to the WebFX a US-based digital marketing agency, medical technology companies generally allocate 5.1% of their yearly revenue towards research and development projects. R&D expenditures for MedTech businesses in the US and the UK increased by 11.5%. Therefore, the increased research and development spending drove the growth of the tumor embolization devices market during the historic period.

Development Of New Systems Or Platforms For Precise Tumor Embolization

Companies in the tumor embolization devices market are focusing on developing innovative systems or platforms for precise tumor embolization to strengthen their position in the market. For instance, in November 2023, Fluidx Medical Technology, a US-based medical device company, developing embolic material and other technologies, revealed information about their new ULTRA embolic platform, which is intended to make therapeutic embolization procedures safer, better and faster. The ULTRA platform is intended to meet the demands of patients requiring moderately distal to proximal tumor embolization. Additionally, in June 2022, Siemens Healthineers, a Germany-based medical technology company that provides healthcare solutions and services, introduced Artis, a new, ceiling-mounted icono ceiling angiography system for precise tumor embolization. The new Artis icono ceiling assists medical personnel in performing with an extremely high level of precision, by combining mechanical flexibility, high positioning accuracy and intelligent operations.

The global tumor embolization devices market is concentrated, with a few players operating in the market. The top ten competitors in the market made up 42.39% of the total market in 2022.

Tumor Embolization Devices Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tumor embolization devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Where is the largest and fastest-growing market for tumor embolization devices? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tumor embolization devices market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider tumor embolization devices market; and compares it with other markets.

The report covers the following chapters

Markets Covered:

Table of Contents

1 Executive Summary

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

7 Tumor Embolization Devices Market - Macro Economic Scenario

8 Major Market Trends

9 Global Market Size and Growth

10 Global Tumor Embolization Devices Market Segmentation

11 Tumor Embolization Devices Market, Regional and Country Analysis

12 Asia-Pacific Market

13 Western Europe Market

14 Eastern Europe Market

15 North America Market

16 South America Market

17 Middle East Market

18 Africa Market

19 Competitive Landscape And Company Profiles

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

23 Opportunities And Strategies

24 Tumor Embolization Devices Market, Conclusions And Recommendations

25 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â